![Alain Dugal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 7 490 $ op 31-05-2026
Mr. Alain R.
Dugal is a Chief Operating Officer & Executive Vice President at LSL Pharma Group, Inc. Mr. Dugal was previously employed as a Vice President-Manufacturing & Logistics by Crescita Therapeutics, Inc.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
LSL PHARMA GROUP INC 0,02% | 28-05-2026 | 29.487 ( 0,02% ) | 7 490 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| LSL PHARMA GROUP INC. | Operationeel Directeur | 28-05-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| CRESCITA THERAPEUTICS INC. | Corporate Officer/Principal | 01-10-2021 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 2 |
|---|---|
Crescita Therapeutics, Inc.
 Crescita Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the production and development of topical products for treating medical conditions in dermatology and pain | Health Technology |
LSL Pharma Group, Inc.
 LSL Pharma Group, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops, manufactures and distributes natural health products & dietary supplements | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
